incite
发表于 2025-3-23 11:54:43
http://reply.papertrans.cn/23/2212/221186/221186_11.png
仇恨
发表于 2025-3-23 15:06:46
Novel Biological Therapies with Direct Application to the Peritoneal Cavityll-associated antigens in a virus-induced, highly inflammatory tumor micromilieu, whereas ICIs optimize the execution of a systemic antitumoral immune response by releasing the “brakes” of the immune system, thus enabling T cells to kill cancer cells more efficiently. This and similar biotherapeutic
确定方向
发表于 2025-3-23 19:46:12
http://reply.papertrans.cn/23/2212/221186/221186_13.png
强行引入
发表于 2025-3-23 22:53:22
http://reply.papertrans.cn/23/2212/221186/221186_14.png
Brain-Waves
发表于 2025-3-24 02:29:14
Data for HIPEC in Colorectal Cancer (T4 Lesions and Metastases)nd HIPEC for advanced colorectal cancer remain high, it is within a range established for other interventions for advanced cancers and has been shown to improve with increased surgeon and institution experience. Though HIPEC was initially introduced for the management of established peritoneal carci
Trigger-Point
发表于 2025-3-24 09:25:22
Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Peritoneal Metastasis eft behind after complete cytoreduction of macroscopic PM might be completely eradicated by HIPEC and postoperative chemotherapy..The comprehensive treatment is promising for GC-PM and brings cure in selected patients with PCI less than cutoff level who received complete cytoreduction and HIPEC. Bec
Cervical-Spine
发表于 2025-3-24 11:19:34
http://reply.papertrans.cn/23/2212/221186/221186_17.png
食料
发表于 2025-3-24 16:48:20
http://reply.papertrans.cn/23/2212/221186/221186_18.png
天文台
发表于 2025-3-24 19:51:36
https://doi.org/10.1057/9781137304483hat can be gained when the immune system is directed to target solid tumors. We also examine the technologies supporting regional delivery and discuss how existing infusion practices are used to treat solid tumors.
Ingest
发表于 2025-3-25 00:19:38
Regional Gene Therapy for Cancerhat can be gained when the immune system is directed to target solid tumors. We also examine the technologies supporting regional delivery and discuss how existing infusion practices are used to treat solid tumors.